Motus GI Holdings

<!-- Name:DistributionId Value:8841921 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

<!-- Name:DistributionId Value:8840988 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

Pre-clinical tests show enhanced functionality of Pure-Vu EVS that can enable physicians to overcome common visualization challenges encountered during emergency upper GI bleeding proceduresAdditional pre-clinical and clinical tests of…

– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation FORT LAUDERDALE, Fla., May 24, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS)…

Topline data expected to be presented at a scientific conference in May 2022Independent data shows ~5.4M outpatient colonoscopies are performed in EU annually1New study data expected to further aid in commercial adoption FORT LAUDERDALE,…